Flowflex SARS-CoV-2 Antigen Rapid Test is a lateral flow chromatographic immunoassay for qualitative detection of the nucleocapsid protein antigen of SARS-CoV-2 in nasal swabs directly from individuals who are suspected of an active COVID-19 infection by the their healthcare providers within the first seven days after the onset of symptoms.
Practical samples in the nose
Fast results in 15 minutes
Excellent performance compared to molecular PCR methods
Room temperature storage
Packaging
Divisional packaging: 25 pieces
Transport packaging: 800 pcs
Nitgatan 11
SE-333 33 Smålandsstenar
Tel: +46 (0)371 330 30
Fax: +46 (0)371 330 31
info@cetromedical.se
